Literature DB >> 11247265

Magnetic resonance imaging findings in tuberculous meningoencephalitis.

M H Pui1, W A Memon.   

Abstract

OBJECTIVE: To evaluate the efficacy of magnetic resonance imaging (MRI) for distinguishing tuberculosis from other types of meningoencephalitis. PATIENTS AND METHODS: MRIs of 100 patients with tuberculous (50), pyogenic (33), viral (14), or fungal (3) meningoencephalitis were analyzed independently by 2 radiologists. Number, size, location, signal characteristics, surrounding edema, and contrast enhancement pattern of nodular lesions; location and pattern of meningeal enhancement; extent of infarct or encephalitis and hydrocephalus were evaluated.
RESULTS: Contrast-enhancing nodular lesions were detected in patients with tuberculous (43 of 50 patients), pyogenic (9 of 33), and fungal (3 of 3) infections. No nodules were detected in patients with viral meningoencephalitis. Using the criteria of 1 or more solid rim or homogeneously enhancing nodules smaller than 2 cm, the sensitivity, specificity and accuracy for diagnosing tuberculous meningitis were 86.0%, 90.0% and 88.0%, respectively.
CONCLUSION: Magnetic resonance imaging is useful in distinguishing tuberculous from pyogenic, viral and fungal meningoencephalitis.

Entities:  

Mesh:

Year:  2001        PMID: 11247265

Source DB:  PubMed          Journal:  Can Assoc Radiol J        ISSN: 0846-5371            Impact factor:   2.248


  3 in total

1.  Clinicoradiological improvement of intracranial tubercular abscess with medical management alone.

Authors:  Rajendra Singh Jain; Rahul Handa; Kadam Nagpal; Swayam Prakash
Journal:  BMJ Case Rep       Date:  2014-04-17

2.  Tuberculous meningomyelitis in magnetic resonance imaging: A Chinese case report.

Authors:  Xingli Liu; Maoping Rui; Liang Lyu
Journal:  Eur J Radiol Open       Date:  2019-08-08

3.  Idiopathic hypertrophic pachymeningitis with anticardiolipin antibody: A case report.

Authors:  Chi-Shun Wu; Hung-Ping Wang; Sheng-Feng Sung
Journal:  Medicine (Baltimore)       Date:  2021-01-15       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.